BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1655 related articles for article (PubMed ID: 27135926)

  • 1. Landscape of somatic mutations in 560 breast cancer whole-genome sequences.
    Nik-Zainal S; Davies H; Staaf J; Ramakrishna M; Glodzik D; Zou X; Martincorena I; Alexandrov LB; Martin S; Wedge DC; Van Loo P; Ju YS; Smid M; Brinkman AB; Morganella S; Aure MR; Lingjærde OC; Langerød A; Ringnér M; Ahn SM; Boyault S; Brock JE; Broeks A; Butler A; Desmedt C; Dirix L; Dronov S; Fatima A; Foekens JA; Gerstung M; Hooijer GK; Jang SJ; Jones DR; Kim HY; King TA; Krishnamurthy S; Lee HJ; Lee JY; Li Y; McLaren S; Menzies A; Mustonen V; O'Meara S; Pauporté I; Pivot X; Purdie CA; Raine K; Ramakrishnan K; Rodríguez-González FG; Romieu G; Sieuwerts AM; Simpson PT; Shepherd R; Stebbings L; Stefansson OA; Teague J; Tommasi S; Treilleux I; Van den Eynden GG; Vermeulen P; Vincent-Salomon A; Yates L; Caldas C; van't Veer L; Tutt A; Knappskog S; Tan BK; Jonkers J; Borg Å; Ueno NT; Sotiriou C; Viari A; Futreal PA; Campbell PJ; Span PN; Van Laere S; Lakhani SR; Eyfjord JE; Thompson AM; Birney E; Stunnenberg HG; van de Vijver MJ; Martens JW; Børresen-Dale AL; Richardson AL; Kong G; Thomas G; Stratton MR
    Nature; 2016 Jun; 534(7605):47-54. PubMed ID: 27135926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of 7,815 cancer exomes reveals associations between mutational processes and somatic driver mutations.
    Poulos RC; Wong YT; Ryan R; Pang H; Wong JWH
    PLoS Genet; 2018 Nov; 14(11):e1007779. PubMed ID: 30412573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers.
    Nones K; Johnson J; Newell F; Patch AM; Thorne H; Kazakoff SH; de Luca XM; Parsons MT; Ferguson K; Reid LE; McCart Reed AE; Srihari S; Lakis V; Davidson AL; Mukhopadhyay P; Holmes O; Xu Q; Wood S; Leonard C; ; ; ; Beesley J; Harris JM; Barnes D; Degasperi A; Ragan MA; Spurdle AB; Khanna KK; Lakhani SR; Pearson JV; Nik-Zainal S; Chenevix-Trench G; Waddell N; Simpson PT
    Ann Oncol; 2019 Jul; 30(7):1071-1079. PubMed ID: 31090900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The topography of mutational processes in breast cancer genomes.
    Morganella S; Alexandrov LB; Glodzik D; Zou X; Davies H; Staaf J; Sieuwerts AM; Brinkman AB; Martin S; Ramakrishna M; Butler A; Kim HY; Borg Å; Sotiriou C; Futreal PA; Campbell PJ; Span PN; Van Laere S; Lakhani SR; Eyfjord JE; Thompson AM; Stunnenberg HG; van de Vijver MJ; Martens JW; Børresen-Dale AL; Richardson AL; Kong G; Thomas G; Sale J; Rada C; Stratton MR; Birney E; Nik-Zainal S
    Nat Commun; 2016 May; 7():11383. PubMed ID: 27136393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population.
    Meindl A;
    Int J Cancer; 2002 Feb; 97(4):472-80. PubMed ID: 11802209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer.
    Polak P; Kim J; Braunstein LZ; Karlic R; Haradhavala NJ; Tiao G; Rosebrock D; Livitz D; Kübler K; Mouw KW; Kamburov A; Maruvka YE; Leshchiner I; Lander ES; Golub TR; Zick A; Orthwein A; Lawrence MS; Batra RN; Caldas C; Haber DA; Laird PW; Shen H; Ellisen LW; D'Andrea AD; Chanock SJ; Foulkes WD; Getz G
    Nat Genet; 2017 Oct; 49(10):1476-1486. PubMed ID: 28825726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low frequency of large genomic rearrangements of BRCA1 and BRCA2 in western Denmark.
    Thomassen M; Gerdes AM; Cruger D; Jensen PK; Kruse TA
    Cancer Genet Cytogenet; 2006 Jul; 168(2):168-71. PubMed ID: 16843109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational processes molding the genomes of 21 breast cancers.
    Nik-Zainal S; Alexandrov LB; Wedge DC; Van Loo P; Greenman CD; Raine K; Jones D; Hinton J; Marshall J; Stebbings LA; Menzies A; Martin S; Leung K; Chen L; Leroy C; Ramakrishna M; Rance R; Lau KW; Mudie LJ; Varela I; McBride DJ; Bignell GR; Cooke SL; Shlien A; Gamble J; Whitmore I; Maddison M; Tarpey PS; Davies HR; Papaemmanuil E; Stephens PJ; McLaren S; Butler AP; Teague JW; Jönsson G; Garber JE; Silver D; Miron P; Fatima A; Boyault S; Langerød A; Tutt A; Martens JW; Aparicio SA; Borg Å; Salomon AV; Thomas G; Børresen-Dale AL; Richardson AL; Neuberger MS; Futreal PA; Campbell PJ; Stratton MR;
    Cell; 2012 May; 149(5):979-93. PubMed ID: 22608084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The landscape of cancer genes and mutational processes in breast cancer.
    Stephens PJ; Tarpey PS; Davies H; Van Loo P; Greenman C; Wedge DC; Nik-Zainal S; Martin S; Varela I; Bignell GR; Yates LR; Papaemmanuil E; Beare D; Butler A; Cheverton A; Gamble J; Hinton J; Jia M; Jayakumar A; Jones D; Latimer C; Lau KW; McLaren S; McBride DJ; Menzies A; Mudie L; Raine K; Rad R; Chapman MS; Teague J; Easton D; Langerød A; ; Lee MT; Shen CY; Tee BT; Huimin BW; Broeks A; Vargas AC; Turashvili G; Martens J; Fatima A; Miron P; Chin SF; Thomas G; Boyault S; Mariani O; Lakhani SR; van de Vijver M; van 't Veer L; Foekens J; Desmedt C; Sotiriou C; Tutt A; Caldas C; Reis-Filho JS; Aparicio SA; Salomon AV; Børresen-Dale AL; Richardson AL; Campbell PJ; Futreal PA; Stratton MR
    Nature; 2012 May; 486(7403):400-4. PubMed ID: 22722201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area.
    Pohlreich P; Zikan M; Stribrna J; Kleibl Z; Janatova M; Kotlas J; Zidovska J; Novotny J; Petruzelka L; Szabo C; Matous B
    Breast Cancer Res; 2005; 7(5):R728-36. PubMed ID: 16168118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing.
    de la Hoya M; Osorio A; Godino J; Sulleiro S; Tosar A; Perez-Segura P; Fernandez C; Rodríguez R; Díaz-Rubio E; Benítez J; Devilee P; Caldés T
    Int J Cancer; 2002 Feb; 97(4):466-71. PubMed ID: 11802208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pan-cancer analysis of whole genomes.
    ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium
    Nature; 2020 Feb; 578(7793):82-93. PubMed ID: 32025007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese breast cancer assays with tumor-only targeted sequencing: extended data analysis from the VGH-TAYLOR study.
    Cheng HF; Tsai YF; Liu CY; Hsu CY; Lien PJ; Lin YS; Chao TC; Lai JI; Feng CJ; Chen YJ; Chen BF; Chiu JH; Tseng LM; Huang CC
    Breast Cancer Res; 2023 Dec; 25(1):152. PubMed ID: 38098088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A whole-genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor-negative and -positive breast cancers.
    Natrajan R; Mackay A; Lambros MB; Weigelt B; Wilkerson PM; Manie E; Grigoriadis A; A'Hern R; van der Groep P; Kozarewa I; Popova T; Mariani O; Turaljic S; Furney SJ; Marais R; Rodruigues DN; Flora AC; Wai P; Pawar V; McDade S; Carroll J; Stoppa-Lyonnet D; Green AR; Ellis IO; Swanton C; van Diest P; Delattre O; Lord CJ; Foulkes WD; Vincent-Salomon A; Ashworth A; Stern MH; Reis-Filho JS
    J Pathol; 2012 May; 227(1):29-41. PubMed ID: 22362584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
    Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
    Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel somatic mutations in the BRCA1 gene in sporadic breast tumors.
    Janatova M; Zikan M; Dundr P; Matous B; Pohlreich P
    Hum Mutat; 2005 Mar; 25(3):319. PubMed ID: 15712267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
    Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
    Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer.
    Yassaee VR; Zeinali S; Harirchi I; Jarvandi S; Mohagheghi MA; Hornby DP; Dalton A
    Breast Cancer Res; 2002; 4(4):R6. PubMed ID: 12100744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer.
    Steinmann D; Bremer M; Rades D; Skawran B; Siebrands C; Karstens JH; Dörk T
    Br J Cancer; 2001 Sep; 85(6):850-8. PubMed ID: 11556836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting the mutational signature of homologous recombination deficiency in clinical samples.
    Gulhan DC; Lee JJ; Melloni GEM; Cortés-Ciriano I; Park PJ
    Nat Genet; 2019 May; 51(5):912-919. PubMed ID: 30988514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 83.